Show items per page
Elements: 35
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Antivirale Substanzen: Gegen was? Fur wen? Hirschel, Bernard 1990
add to browser selection
Combination therapy in primary HIV infection Perrin, Luc; Hirschel, Bernard 1996
add to browser selection
Adding saquinavir to stavudine in patients with advanced HIV-1 infection Rutschmann, Olivier Thierry; Kaiser, Laurent; Perrin, Luc; Fathi, Marc; Hirschel, Bernard 1997
add to browser selection
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study Egger, M.; Hirschel, Bernard; Francioli, Patrick; Sudre, Philippe; ... Battegay, M. 1997
add to browser selection
Progress and problems in the fight against AIDS Hirschel, Bernard; Francioli, P. 1998
add to browser selection
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study Zinkernagel, C.; Ledergerber, Bruno; Battegay, M.; Cone, R. W.; ... Opravil, M. 1999
add to browser selection
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Vernazza, P. L.; Bucher, H. C.; Opravil, M.; ... Hirschel, Bernard 2000
add to browser selection
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group Joly, V.; Moroni, M.; Concia, Ercole; Lazzarin, A.; ... de Cian, W. 2000
add to browser selection
Modern anti-HIV therapy Flepp, Markus; Schiffer, V.; Weber, R.; Hirschel, Bernard 2001
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients Battegay, M.; Vernazza, P. L.; Bernasconi, Enos; Flepp, Markus; ... Hirschel, Bernard 2001
add to browser selection
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000 Bernasconi, Enos; Jost, J.; Ledergerber, Bruno; Hirschel, Bernard; ... Sudre, Philippe 2001
add to browser selection
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio 2002
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection Hirsch, M. S.; Steigbigel, R. T.; Staszewski, Scholomo; McMahon, Deborah; ... Leavitt, R. Y. 2003
add to browser selection
Beware of drug holidays before HIV salvage therapy Hirschel, Bernard 2003
add to browser selection
Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg Ananworanich, Jintanat; Siangphoe, Umaporn; Mahanontharit, Apicha; Hill, Andrew; ... Ruxrungtham, Kiat 2004
add to browser selection
Sida Molécules récentes, stratégies thérapeutiques d'avenir et nouvelles cibles du traitement Delessert, K.; Schiffer, V.; Hirschel, Bernard 2005
add to browser selection
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel 2005
add to browser selection
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study Ananworanich, Jintanat; Siangphoe, Umaporn; Hill, Andrew; Cardiello, Peter; ... Ruxrungtham, Kiat 2005
add to browser selection
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study Glass, T. R.; De Geest, Sabina; Weber, Rainer; Vernazza, P. L.; ... Bucher, H. C. 2006
add to browser selection
VIH – sida Traitement de l'infection à VIH en 2006 : points forts Schiffer, V.; Hirschel, Bernard 2007
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study Fux, C. A.; Simcock, Mathew; Wolbers, Marcel; Bucher, H. C.; ... Furrer, Hansjakob 2007
add to browser selection
No patient left behind--better treatments for resistant HIV infection Hirschel, Bernard; Perneger, Thomas 2007
add to browser selection
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study Fux, C. A.; Rauch, Andri; Simcock, Mathew; Bucher, H. C.; ... Furrer, Hansjakob 2008
add to browser selection
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007 Ballif, Marie; Ledergerber, Bruno; Battegay, Manuel; Cavassini, Matthias; ... Weber, Rainer 2009
add to browser selection
Safety and efficacy of once-daily nevirapine dosing: a multicohort study Calmy, Alexandra; Vallier, Nathalie; Nguyen, Alain; Lange, J. M.; ... Wit, F. W. 2009
add to browser selection
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study Conen, Anna; Fehr, Jan; Glass, T. R.; Furrer, Hansjakob; ... Battegay, Manuel 2009
add to browser selection
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV Young, Jim; Bucher, H. C.; Guenthard, H. F.; Rickenbach, Martin; ... Battegay, Manuel 2009
add to browser selection
Is it smart to continue to study treatment interruptions? Hirschel, Bernard; Flanigan, Timothy 2009
add to browser selection
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures Scherrer, A. U.; von Wyl, Viktor; Fux, C. A.; Opravil, Milos; ... Gunthard, Huldrych 2010